2008 in Denmark

controversy relating to the publication of depictions of the Islamic prophet Muhammad

thumb|Semaglutide (Ozempic) Autoinjector|self-injection pen thumb|Prescription vial of semaglutide (Rybelsus) pills Semaglutide is an anti-diabetic medication used for the treatment of type2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the bra

earthquake in Sweden